In breast and colon cancers, TGFβ signaling exerts antineoplastic effect during early stages, but eventually it promotes carcinogenesis through mediating epithelial mesenchymal transition (EMT)28. The gene discussed is TGFB1; the disease is malignant colon neoplasm.